Drug interactions
Oxybutynin transdermal + Rivastigmine
Severity: Moderate
Oxybutynin transdermal and Rivastigmine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Oxybutynin is an anticholinergic that crosses the blood-brain barrier and opposes rivastigmine, potentially worsening cognition in dementia. The transdermal form lowers active metabolite exposure but still has systemic effects.
What this interaction means in plain words
Oxybutynin transdermal and Rivastigmine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Pharmacodynamic antagonism through muscarinic receptor blockade.
What to do
Prefer a beta-3 agonist or trospium for overactive bladder in patients with dementia. If oxybutynin is used, monitor cognition and bladder response.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Rivastigmine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Rivastigmine
Frequently asked questions
Can I take Oxybutynin transdermal with Rivastigmine?
MediHelp rates the interaction as moderate. Oxybutynin transdermal and Rivastigmine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxybutynin is an anticholinergic that crosses the blood-brain barrier and opposes rivastigmine, potentially worsening cognition in dementia. The transdermal form lowers active metabolite exposure but still has systemic effects.
How serious is the interaction between Oxybutynin transdermal and Rivastigmine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a beta-3 agonist or trospium for overactive bladder in patients with dementia. If oxybutynin is used, monitor cognition and bladder response.
What other medicines interact with Rivastigmine?
MediHelp also lists interactions of Rivastigmine with, for example, Donepezil, Galantamine, Memantine-donepezil. The full list is on the Rivastigmine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
